Molecule Holdings Inc.
MLCL
CNSX
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 15.38% | 18.67% | 21.62% | -4.63% | 30.25% |
| Total Depreciation and Amortization | -4.92% | -6.03% | -5.47% | 11.84% | 55.07% |
| Total Amortization of Deferred Charges | -109.78% | -40.18% | -66.21% | -66.21% | -88.40% |
| Total Other Non-Cash Items | 61.52% | -16.45% | -70.74% | -44.77% | -70.34% |
| Change in Net Operating Assets | 877.11% | 6,720.34% | 275.03% | 240.63% | 128.67% |
| Cash from Operations | 96.03% | 85.14% | 86.01% | 60.86% | -2.93% |
| Capital Expenditure | 100.00% | 107.55% | 142.35% | 56.33% | 93.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 53.28% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3,029.17% | 26.06% | -99.85% | -98.06% | -99.07% |
| Cash from Investing | 477.69% | -19.05% | -76.39% | -117.32% | -79.53% |
| Total Debt Issued | -66.05% | -68.33% | -75.25% | -75.25% | -52.89% |
| Total Debt Repaid | -820.41% | -394.32% | -400.32% | -406.80% | -3.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.89% | 7.34% | -6.75% | -34.67% | 25.76% |
| Cash from Financing | -107.34% | -91.89% | -96.50% | -98.63% | -59.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.12% | -200.77% | -571.52% | -428.46% | -277.79% |